Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell

Pancreatology

Volumn 11, Issue 6, 2011, Pages 601-609

  Mo, Wenhui ^a   Xu, Xuanfu ^a   Xu, Ling ^a   Wang, Feng ^a   Ke, Aiwu ^a   Wang, Xingpeng ^a   Guo, Chuanyong ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Apoptosis; Hedgehog signaling pathway; Pancreatic cancer; Proliferation; Resveratrol

Indexed keywords

BAG 1 PROTEIN; CHOLECYSTOKININ OCTAPEPTIDE; LUCIFERASE; PROTEIN PATCHED 1; RESVERATROL; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84862781019     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000333542     Document Type: Article

References (34)

1. Kayahara M, Funaki K, Tajima H, Takamura H, Ninomiya I, Kitagawa H, Ohta T: Surgical implication of micrometastasis for pancreatic cancer. Pancreas 2010; 39: 884-888.
2. Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG: Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: A population-based analysis. Cancer 2010; 116: 2932-2940.
3. Richter J, Saif MW: Updates in adjuvant therapy in pancreatic cancer: Gemcitabine and beyond. Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium', Orlando, USA. JOP 2010; 11: 144-147.
4. Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004; 363: 1049-1057. (Pubitemid 38410779)
5. Hebrok M: Hedgehog signaling in pancreas development. Mech Dev 2003; 120: 45-57. (Pubitemid 35462095)
6. Caro I, Low JA: The role of the Hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 2010; 16: 3335-3339.
7. Barginear MF, Leung M, Budman DR: The Hedgehog pathway as a therapeutic target for treatment of breast cancer. Breast Cancer Res Treat 2009; 116: 239-246.
8. Saqui-Salces M, Merchant JL: Hedgehog signaling and gastrointestinal cancer. Biochim Biophys Acta 2010; 1803: 786-795.
9. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425: 851-856. (Pubitemid 37355945)
10. Jones S, Zhang X, Parsons DW, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321: 1801-1806.
11. Feldmann G, Habbe N, Dhara S, Bisht S, Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy N, Ouellette MM, Yu W, Maitra A: Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 2008; 57: 1420-1430.
12. Lee CJ, Dosch J, Simeone DM: Pancreatic cancer stem cells. J Clin Oncol 2008; 6: 2806-2812.
13. Mueller MT, Hermann PC, Witthauer J, Rubio-Viqueira B, Leicht SF, Huber S, Ellwart JW, Mustafa M, Bartenstein P, D'Haese JG, Schoenberg MH, Berger F, Jauch KW, Hidalgo M, Heeschen C: Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 2009; 137: 1102-1113.
14. Jimeno A, Feldmann G, Suárez-Gauthier A, Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, García-García E, López-Ríos F, Matsui W, Maitra A, Hidalgo M: A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 2009; 8: 310-314.
15. Pervaiz S, Holme AL: Resveratrol: Its biologic targets and functional activity. Antioxid Redox Signal 2009; 11: 2851-2897.
16. Jang M, Cai L, Udeani GO, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-220. (Pubitemid 127696281)
17. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytother Res 2010; 24: 1637-1644.
18. Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, Bode AM, Dong Z: Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene a4 hydrolase. Cancer Res 2010; 70: 9755-9764.
19. Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB: Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 2010; 127: 257-268.
20. Wang F, Xu L, Guo C, Ke A, Hu G, Xu X, Mo W, Yang L, Huang Y, He S, Wang X: Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PloS One 2011; 11:e18434.
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
22. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y: Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004; 24: 2783-2840. (Pubitemid 39409568)
23. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL: Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 2009; 486: 95-102.
24. Delmas D, Solary E, Latruffe N: Resveratrol, a phytochemical inducer of multiple cell death pathways: Apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 2011; 18: 1100-1121.
25. Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 2011; 6:e16530.
26. Tili E, Michaille JJ: Resveratrol, MicroRNAs, inflammation, and cancer. J Nucl Acids 2011; 2011: 102431.
27. Araújo JR, Gonçalves P, Martel F; Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 2011; 31: 77-87.
28. Xu FG, Ma QY, Wang Z: Blockade of Hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer. Cancer Lett 2009; 283: 119-124.
29. Takaori K: Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg 2007; 14: 217-223. (Pubitemid 46863909)
30. Katoh Y, Katoh M: Hedgehog target genes: Mechanisms of carcinogenesis induced by aberrant Hedgehog signaling activation. Curr Mol Med 2009; 9: 873-886.
31. Colin D, Limagne E, Jeanningros S, Jacquel A, Lizard G, Athias A, Gambert P, Hichami A, Latruffe N, Solary E, Delmas D: Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev Res 2011: 1095-1106.
32. Kasper M, Schnidar H, Neill GW, Hanneder M, Klingler S, Blaas L, Schmid C, Hauser-Kronberger C, Regl G, Philpott MP, Aberger F: Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 2006; 26: 6283-6298. (Pubitemid 44204544)
33. Hegde GV, Peterson KJ, Emanuel K, Mittal AK, Joshi AD, Dickinson JD, Kollessery GJ, Bociek RG, Bierman P, Vose JM, Weisenburger DD, Joshi SS: Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: A potential new therapeutic target. Mol Cancer Res 2008; 6: 1928-1936.
34. Wang K, Pan L, Che X, Cui D, Li C: Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines. J Neurooncol 2010; 98: 319-327.